Long-term follow-up after hip surgery with FH ORTHO implants
Official title: Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices (FH ORTHO Company Hip Observatory).
Run by Fh Ortho · NCT05966220 · Data updated 2026-11-12
This follow-up will collect real-world safety and performance data on FH ORTHO hip implants in adults who receive them.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Fh Ortho Industry-sponsored |
| Locations | 5 sites (Guilherand-Granges and 4 other locations) |
| Status | Recruiting |
| Started | January 8, 2024 |
| Main results expected | December 2038 |
| Study ends | December 2038 |
| Registry record updated | February 2, 2026 |
| Trial ID | NCT05966220 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years and older) who receive or have received FH ORTHO hip implants at participating centers and can provide informed consent are eligible candidates.
✕Probably not a fit
Patients with active or latent infection, known severe bone insufficiency, certain neuromuscular or mental disorders that increase prosthetic risk, or known allergy to device materials are excluded or unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This post-market clinical follow-up (PMCF) observatory gathers clinical data from adult patients receiving FH ORTHO devices for hip arthroplasty or trauma repair at participating centers. A dynamic cohort design allows new inclusions during the enrollment period and replacements for premature exits to maintain follow-up. Surgeons will record device models, implant combinations, and perioperative details in electronic case report forms, while clinical outcomes and complications are captured during routine visits. The registry aims to cover different device versions and combinations to monitor safety, performance, and residual risks under normal use and to meet local regulatory requirements.
Why it matters
Potential benefit: If successful, this effort could improve knowledge of long-term safety and performance of FH ORTHO hip implants and help detect device-related problems earlier.
How similar studies have gone: Similar post-market registries for hip implants have often provided useful safety signals and performance information, although results vary by device and study design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO Company for hip arthroplasty and traumatology, used in accordance with their approved Instruction For Use, in one of the centers participating in the Observatory. 2. Patient is at least 18 years of age. 3. Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally). 4. In some countries, such as France, the patient will have to be socially insured to be included in the study. Exclusion Criteria: 1. An infection, or latent infection. 2. A mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, failure of prosthetic fixation, or post-operative complications (except for the HIP\&GO Double mobility cemented cup and, if applicable, the associated stems and heads when assembled together). 3. Known Insufficient bone quality and/or bone stock. 4. Known allergy to any component of the material listed on the product label. 5. Metabolic diseases that could compromise bone regrowth. 6. Metabolic and/or vascular treatment or disease that may compromise bone healing or consolidation. 7. Drug dependency. 8. Uncooperative patient unable to follow recommendations. 9. Protected adult
Where it's running
-
Clinique Pasteur
Guilherand-Granges, France Recruiting -
Centre Hospitalier Du Haut Bugey
Oyonnax, France Recruiting -
Polyclinique Reims-Courlancy
Reims, France Recruiting -
Clinique Mutualiste La Sagesse
Rennes, France Recruiting -
Clinique de l'Atlantique
Saint-Herblain, France Recruiting
Study contacts
- Study coordinator: Vincent GAUDIOT, MD
- Email: vincent.gaudiot@wanadoo.fr
- Phone: +33 2 40 95 92 81
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quadro-Iliac Plane Block for Hip Surgery: Observational Insights
This study tests how well the QIP block, used during hip surgery, works for pain and recovery compared with other regional anesthesia techniques.
-
PENG versus Deep Iliacus Plane block for pain relief in intertrochanteric femur fractures
This study will see if PENG or Deep Iliacus Plane nerve blocks give better pain relief and make positioning for spinal anesthesia easier for adults having surgery for intertrochanteric hip fractures.
-
Electrically powered leg exercise device to improve walking after hip surgery
This will test whether an electrically powered orthopedic exercise device helps people who recently had hip surgery walk farther, faster, and keep their balance better.
-
Regional nerve blocks for anterior-approach hip replacement (SIFI vs ESP)
This trial will test whether adding a supra-inguinal fascia iliaca (SIFI) block or an erector spinae plane (ESP) block can reduce early pain and opioid side effects after elective anterior approach total hip replacement in adults.
-
Using melatonin to improve recovery in teens after surgery
This study is testing if melatonin can help teenagers recover better and sleep well after having major surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.